Kate is a Senior Commercialisation Associate in the Life Sciences team.
She identifies and evaluates new technologies arising from University research, supporting inventors with the protection of their intellectual property and commercialisation of their research.
Prior to joining Cambridge Enterprise, Kate worked in the commercialisation team at The Babraham Institute where she managed the intellectual property portfolio and supported industry and academic relationships. She developed her scientific background in virology and immunology during her PhD in Virology from the Faculty of Medicine, Imperial College London. She also has an MScR in Infection and Immunity from the University of Edinburgh and has co-authored five academic publications.
Kate joined Cambridge Enterprise in June 2023.
